academic article

• Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study..  BMC cancer.  16:-. 2016
• Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide..  Leukemia & lymphoma.  :1-9. 2016
• TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients. 2013
• Telomere length in myelodysplastic syndromes..  Leukemia & lymphoma.  52:1528-1536. 2011